Updated Story President Donald Trump spoke by phone to heads of pharmaceutical and biotech companies on Monday afternoon (April 6) about the status of research on COVID-19 drugs. Some of the executives lead companies that recently received significant funding from the federal government to develop COVID-19 drugs. Participants included Amgen CEO Robert Bradway, Genentech CEO Alexander Hardy, Gilead CEO Daniel O’Day and Regeneron CEO Leonard Schliefer. The White House said the drug makers and Trump discussed the...